In the UK, typical oral doses for dietary deficiency are 50-150 micrograms daily, with higher doses (1000-2000 micrograms) generally reserved for clinical situations under healthcare supervision
Additional risk factors include: Chronic kidney disease : Reduced renal clearance may impair B12 excretion Liver disease : Hepatic dysfunction can disrupt B12 metabolism and storage Myeloproliferative disorders : Certain blood cancers increase B12-binding proteins Concurrent medication use : Some drugs may interact with B12 metabolism, including metformin, proton pump inhibitors, and H2 antagonists Patients with these conditions should have B12 supplementation carefully monitored by their healthcare team
Why is Hycomin Injection recommended
The decision of when to start B12 injections is individual and depends on factors like the severity of the deficiency, the underlying cause, and the patients health status
B-12 supports red blood cell formation, neurological function, and DNA synthesis, making it a foundational treatment for fatigue, cognitive performance, and metabolic health